Skip to main content
Equibles

Pacer Advisors, Inc.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1616667 Malvern, PA
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,850,256
-$1,249,460 QoQ
Shares Held
228,060
-22.8% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#89
of 667 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Pacer Advisors, Inc. holds $626,935,191 across 141 Biotechnology names. HALO ranks #7 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 369,451 $230,367,476
2 INCY
Incyte Corp
 1,431,426 $162,266,451
3 EXEL
Exelixis, Inc.
 1,096,682 $59,670,467
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 72,465 $35,995,539
5 JAZZ
Jazz Pharmaceuticals plc
 146,264 $35,245,236
6 BMRN
Biomarin Pharmaceutical Inc
 506,545 $28,984,504
7 HALO
Halozyme Therapeutics, Inc.
This page 		228,060 $17,850,256
8 HRMY
Harmony Biosciences Holdings, Inc.
 348,239 $12,679,381

All Filings in HALO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,850,256 228,060
2026-03-31 $19,099,716 295,524
2025-12-31 $63,079,818 937,293
2025-09-30 $35,120,619 478,874
2025-06-30 $1,156,144 22,225
2025-03-31 $739,813 11,594
2024-12-31 $1,386,776 29,006
2024-09-30 $1,674,899 29,261
2024-06-30 $1,541,792 29,446
2024-03-31 $1,135,622 27,916
2023-12-31 $974,856 26,376
2023-09-30 $424,593 11,115
2023-06-30 $1,204,016 33,380
2023-03-31 $316,977 8,300
2022-12-31 $1,474,620 25,916
2022-09-30 $233,088 5,895
2021-12-31 $599,611 14,912
2021-09-30 $795,375 19,552
2021-06-30 $630,472 13,884
2021-03-31 $656,325 15,743
2020-12-31 $494,496 11,578
2020-09-30 $121,045 4,606